'I was glad I had gone to the doctor early.'
When Noeleen McMorris found herself with a regular influx of hiccups, indigestion and a change in swallowing habits, she knew something was wrong.
“Although it was a big shock, I was glad I had gone to the doctor early. I could so easily have ignored it and not done anything for months. I was really grateful my GP was on the ball and pushed for an endoscopy because I had a healthy lifestyle and didn’t fit the typical statistics of being an older man, a smoker or a drinker.”
“Overall it has been a rollercoaster but I’m well enough down the line now to appreciate that I am healthy. I deal with the symptoms, and I know how to adjust to cope with them and I positively encourage myself to eat healthily and eat properly.” "But with charity meetups and events, I’ve been able to see people post-recovery, enjoying a great life. It’s given me a much more positive outlook. OG Cancer was a great help for advice and support, and still are.”
The long-term objective of the mobile unit is to spread awareness in order to increase survival rates.Falling under the Belfast Live banner, MyDerry is part of our drive to cover news, people and events in your area. “My gut feeling was telling me ‘something is wrong’ but I didn’t think it was cancer. Other than the hiccups I wasn’t feeling in any way ill. I could have very easily ignored it, or put it off. I think it’s important to realise that just because you don’t fit in the statistics, doesn’t mean you won’t be at risk.”
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hearing loss and tinnitus are common in cancer survivorsWhile children receiving chemotherapy routinely undergo hearing tests, adults don't, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer.
Read more »
Latest Spain rules tourists need to know from bikini bans to alcohol limitsIf you are heading to Spain soon, there are a few rules you will want to read up on if you want to avoid being fined, and many of the rules have nothing to do with covid.
Read more »
'Irreplaceable legend' Paisley DJ dies after battle with cancerLegendary Paisley DJ Stephen McIntyre has tragically died following a battle with cancer.
Read more »
MPs call for 'menopause leave' trial to support women at workA report from the Women and Equalities Committee says 'stigma, shame and dismissive cultures... must be dismantled' as symptoms can have a 'sometimes debilitating impact' on women.
Read more »
Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical TrialABSTRACT Objective: Therapeutic options are limited for treatment-resistant bipolar depression (TRBD). Insulin resistance (IR) confers increased risk for TRBD. We investigated metformin, an insulin sensitizer, to reverse IR and improve clinical outcomes in TRBD. Methods: Using a random-assignment (1:1), intent-to-treat, 2-site, quadruple-masked, parallel-group (metformin to 2,000 mg/d or placebo) clinical trial design, patients with DSM-5 bipolar disorder (BD) type I or II and IR received study medication for 26 weeks (February 2016 to October 2019). The primary outcome was the change in depression rating scores (Montgomery-Asberg Depression Rating Scale ) at 14 weeks between those who no longer met IR criteria (converters) and those who still did (non-converters). Additional outcomes included scores on the Global Assessment of Functioning (GAF); the Clinical Global Impressions Scale, Bipolar Disorders version (CGI-BP); and the Hamilton Anxiety Rating Scale (HAM-A) and maintenance of improved outcomes up to 26 weeks. Results: Forty-five BD patients were randomized to metformin (n = 20) or placebo (n = 25), and at 14 weeks or later, 11 subjects no longer met IR criteria (n = 10 with metformin, n = 1 with placebo; P = .0009). These converters experienced significant improvements in MADRS (P values ranged from .031 to .008) and GAF (P values ranged from .045 to .008) scores compared to non-converters beginning at week 6, sustained to week 26. HAM-A (P = .022 at week 14 and .019 at week 26) and CGI-BP change scores (P = .046 at 26 weeks) significantly favored converters over non-converters. Effect sizes were large for the MADRS and GAF (Cohen d | 1 at 14 and 26 weeks) and large for the HAM-A and CGI-BP at 26 weeks. Transient gastrointestinal side effects occurred under both treatment conditions. Conclusions: Pending replication, this early study suggests that reversal of IR by metformin offers a path out of TRBD. Further characterization of metformin converters with TRB
Read more »
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice - Nature CommunicationsTriclosan is an antimicrobial additive in consumer products that has been detected in human breast milk. Here the authors report that exposure of pregnant mice to triclosan leads to lactational exposure to newborns and the development of liver steatosis.
Read more »